These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse. Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487 [TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication. Galicia M; Dargan PI; Dines AM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Wood DM; Miró Ò; Toxicol Lett; 2019 Oct; 314():37-42. PubMed ID: 31301370 [TBL] [Abstract][Full Text] [Related]
6. Adverse events associated with ingestion of gamma-butyrolactone--Minnesota, New Mexico, and Texas, 1998-1999. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1999 Feb; 48(7):137-40. PubMed ID: 10077458 [TBL] [Abstract][Full Text] [Related]
7. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723 [TBL] [Abstract][Full Text] [Related]
8. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone. Lenz D; Rothschild MA; Kröner L Ther Drug Monit; 2008 Dec; 30(6):755-61. PubMed ID: 18824955 [TBL] [Abstract][Full Text] [Related]
9. [First report of lethal gamma-hydroxybutyrate (GHB) intoxication after consumption of gamma-butyrolactone (GBL) in Lower Saxony]. Fieguth A; Albrecht K; Weller JP; Kühnle R; Teske J Arch Kriminol; 2009; 223(1-2):45-51. PubMed ID: 19323150 [TBL] [Abstract][Full Text] [Related]
10. More on gamma-butyrolactone (GBL/GHB) toxicity. Gensert K J Emerg Nurs; 2001 Feb; 27(1):7-8. PubMed ID: 11174256 [No Abstract] [Full Text] [Related]
11. A case of γ-butyrolactone associated with severe withdrawal delirium and acute renal failure. Bhattacharya IS; Watson F; Bruce M Eur Addict Res; 2011; 17(4):169-71. PubMed ID: 21454980 [TBL] [Abstract][Full Text] [Related]
12. Gamma-butyrolactone (GBL) disruption of passive avoidance learning in the day-old chick appears to be due to its effect on GABAB not gamma-hydroxybutyric [corrected] acid (GHB) receptors. Sherry JM; Hazi A; Hale MW; Milsome SL; Crowe SF Behav Brain Res; 2009 Feb; 197(2):347-55. PubMed ID: 18948143 [TBL] [Abstract][Full Text] [Related]
14. [GHB, GBL and butanediol poisonings--a serious problem in Western Sweden]. Knudsen K; Greter J; Verdicchio M; Cederquist T Lakartidningen; 2005 Nov 7-13; 102(45):3294-6, 3299. PubMed ID: 16342543 [TBL] [Abstract][Full Text] [Related]
15. Extreme γ-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis. Roberts DM; Smith MW; Gopalakrishnan M; Whittaker G; Day RO Ann Emerg Med; 2011 Jul; 58(1):83-5. PubMed ID: 21435738 [TBL] [Abstract][Full Text] [Related]
16. Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre. Liechti ME; Kupferschmidt H Swiss Med Wkly; 2004 Sep; 134(35-36):534-7. PubMed ID: 15517507 [TBL] [Abstract][Full Text] [Related]
17. Unusual presentation of a patient with GBL withdrawal: a case report. Kashyap GL; Patel AG Psychiatr Danub; 2011 Sep; 23 Suppl 1():S32-4. PubMed ID: 21894099 [TBL] [Abstract][Full Text] [Related]
18. [Unconsciousness after ingestion of nail varnish]. Andersen MB; Netterstrøm B Ugeskr Laeger; 1992 Oct; 154(44):3064. PubMed ID: 1462403 [TBL] [Abstract][Full Text] [Related]
19. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review. Ghio L; Cervetti A; Respino M; Belvederi Murri M; Amore M J Psychiatr Pract; 2014 Jul; 20(4):294-300. PubMed ID: 25036586 [TBL] [Abstract][Full Text] [Related]
20. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use. Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]